Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database

Introduction: The benefit of cytoreductive nephrectomy (CN) for metastatic kidney cancer has been challenged recently. The study aimed to evaluate the prognostic roles of surgical resection of primary tumor site for metastatic kidney cancer under a real-world setting. Methods: The Surveillance, Epid...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Cheng, Wang, Ruiliang, Ma, Wenchao, Liu, Shenghua, Yao, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454406/
https://www.ncbi.nlm.nih.gov/pubmed/34557516
http://dx.doi.org/10.3389/fsurg.2021.716455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454406/
https://www.ncbi.nlm.nih.gov/pubmed/34557516
http://dx.doi.org/10.3389/fsurg.2021.716455

Ejemplares similares